NLRP3 and Parkinson disease: Clinical studies have shown that the gut microbiome was altered in PD patients, in addition to the activation of the NLRP3 inflammasome in the gut, periphery, and brain, which may suggest that microbes, NLRP3 inflammasome and PD interact with each other.24